The therapeutic potential of CXC chemokine blockade in acute inflammation in the brain

Bibliography

• PERRY VH, BELL MD, BROWN HC, MATYSZAK MK: In-flammation in the nervous system. Curr. Opin. Neuro-biol. (1995) 5(5):636–641.
   PubMed Web of Science ®Google Scholar
• PERRY VH, ANTHONY DC, BOLTON SJ, BROWN HC: Theblood-brain barrier and the inflammatory response. Mol Med. Today (1997) 3(8):335–341.
   PubMedGoogle Scholar
• WEDMORE CV, WILLIAMS TJ: Control of the vascularpermeability by polymorphonuclear leukocytes in in-flammation. Nature (1981) 289:646–650.
   PubMed Web of Science ®Google Scholar
• ANDERSSON PB, PERRY VH, GORDON S: Intracerebral injection of proinflammatory cytokines or leukocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the central nervous system. J. Exper. Med. (1992) 176(0:255–259.
   PubMedGoogle Scholar
• MARKOWITZ S, SAITO K, MOSKOWITZ MA: Neurogeni-rally mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J. Neurosci. (1987) 7 (1 2):4129–4136.
   Google Scholar
• ANDERSSON PB, PERRY VH, GORDON S: The CNS acute response to excitotoxic neuronal cell death. Immunol. Lett. (1991) 30(2):177–182.
   PubMed Web of Science ®Google Scholar
• •One of the first studies identifying the atypical nature of the acute inflammatory response in the CNS.
   Google Scholar
• ANDERSSON PB, PERRY VH, GORDON S: The acute in-flammatory response to lipopolysaccharide in CNS pa-renchyma differs from that in other body tissues. Neuroscience (1992) 48(0:169–186.
   PubMedGoogle Scholar
• PERRY VH, LAWSON LI REID DM: Biology of the mono-nuclear phagocyte system of the central nervous sys-tem and HIV infection. J. Leukocyte Biol. (1994) 56 (3) 399–406.
   PubMed Web of Science ®Google Scholar
• CLARK RSB, SCHIDING JK, KACZOROWSKI SL, MARION DW, KOCHANEK PM: Neutrophil accumulation after traumatic brain injury in rats: Comparison of weight drop and controlled cortical impact models. J. Neurotr. (1994) 11(5):499–506.
   PubMed Web of Science ®Google Scholar
• MATSUO Y, ONODERA H, SHIGA Y et al.: Correlation be-tween myeloperoxidase-quantified neutrophil accu-mulation and ischemic brain injury in the rat - effects of neutrophil depletion. Stroke (1994) 25(7)1469–1475.
   Google Scholar
• •Study providing clear evidence of a link between neutrophil recruitment, following an ischaemic insult, and damage to the CNS.
   Google Scholar
• ANTHONY DC, BOLTON SJ, FEARN S, PERRY VH: Age-related effects of interleukin-1 beta on polymorpho-nuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain (1997) 120(3)435–444.
   Google Scholar
• JIANG N, MOYLE M, SOULE HR, ROTE WE, CHOPP M: Neu-trophil inhibitory factor is neuroprotective after focal ischemia in rats. Ann. Neurol. (1995) 38(6):935–942.
   PubMed Web of Science ®Google Scholar
• ZHANG ZG, CHOPP M, TANG WX, JIANG N, ZHANG RL: Postischemic treatment (2–4 11) with anti-CD11b and anti-CD18 monoclonal antibodies are neuroprotective after transient (21) focal cerebral ischemia in the rat. Brain Res. (1995) 698(1–2)79–85.
   Google Scholar
• SCHNELL L, FEARN S, SCHWAB ME, PERRY VH, ANTHONYDC: Cytokine-induced acute inflammation in the brain and spinal cord. J. Neuropathol. Exper. Neurol. (1999). (In Press).
   Google Scholar
• NIEMOLLER UM, TAUBER MG: Brain edema and in-creased intracranial pressure in the pathophysiology of bacterial meningitis. Eur. J. Clin. Microbiol. Infect. Dis. (1989) 8:109–117.
   PubMed Web of Science ®Google Scholar
• BOLTON SJ, ANTHONY DA, PERRY VH: Loss of the tightjunction proteins occludin and zonula occludens-1 cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo. Neurosci. (1998) 86(4):1245–1257.
   PubMed Web of Science ®Google Scholar
• •In vivo evidence for the paracellular migration of neutro-phils across the brain endothelium.
   Google Scholar
• ANTHONY DC, MILLER KM, FEARN S et al. Matrix metal- expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS. j Neuroimmunol. (1998) 87(1-2):62–73.
   PubMed Web of Science ®Google Scholar
• ROMANIC AM, WHITE RF, ARLETH AJ, OHLSTEIN EH, BARONE FC: Matrix metalloproteinase expression in-creases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke (1998) 29 (5) :1020–1030.
   PubMed Web of Science ®Google Scholar
• •First study showing that the selective inhibition of a matrix metalloproteinase, employing a neutralizing antibody, can reduce infarct volume.
   Google Scholar
• SEKIDO N, MUKAIDA N, HARADA A, NAKANISHI I, WATANABE Y, MATSUSHIMA K: Prevention of lung reperfusion injury in rabbits by a monoclonal anti-body against interleukin-8. Nature (1 9 9 3) 365 (6447):654–657.
   Google Scholar
• KURTEL H, TSO P, GRANGER DN: Granulocyte accumu-lation in postischemic intestine: role of leukocyte ad-hesion glycoprotein CD11/CD18. Am. J. Physiol. (1992) 262(5 Pt 1):g878–882.
   Google Scholar
• LEFER AM, CAMPBELL B, SCALIA R, LEFER DJ: Synergismbetween platelets and neutrophils in provoking car-diac dysfunction after ischemia and reperfusion: role of selectins. Circulation (1998) 98 (13) :1322–1328.
   PubMed Web of Science ®Google Scholar
• ROTHWELL NJ, HOPKINS SJ: Cytokines and the nervoussystem II: actions and mechanisms of action. Trends Neurosci. (1995) 18(3):130–136.
   PubMed Web of Science ®Google Scholar
• KIM JS: Cytokines and adhesion molecules in strokeand related diseases. J. Neurol. Sci. (1996) 137(2):69–78.
   PubMed Web of Science ®Google Scholar
• HAUSER SL, DOOLITTLE TH, LINCOLN R, BROWN RH, DI-NARELLO CA: Cytokine accumulations in CSF of multi-ple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology (1990) 40(11) :1735–1739.
   PubMed Web of Science ®Google Scholar
• TSUKADA N, MIYAGI K, MATSUDA M, YANAGISAWA N,YONE K: Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis. J. Neurol Sci. (1991) 104(2):230–234.
   PubMed Web of Science ®Google Scholar
• MARTIN D, NEAR SL: Protective effect of theinterleukin-1 receptor antagonist (IL-lra) on experi-mental allergic encephalomyelitis in rats. J. Neuroim-munol (1995) 61(2):241–245.
   PubMed Web of Science ®Google Scholar
• SOMMER N, LOSCHMANN PA, NORTHOFF GH et al. The rolipram suppresses cytokine produc-tion and prevents autoimmune encephalomyelitis. Nature Med. (1995) 1(3):244–248.
   PubMed Web of Science ®Google Scholar
• KWIATKOWSKI D, HILL AVS, SAMBOU I et al.: TNF con- in fatal cerebral, non-fatal cerebral, and un-complicated Plasmodium falciparum malaria. Lancet (1990) 336(8725):1201–1204.
   PubMed Web of Science ®Google Scholar
• MARTIN S, MARUTA K, BURKART V, GILLIS S, KOLB H:IL-1 and IFN-gamma increase vascular permeability. Immunology (1988) 64(2):301–305.
   PubMed Web of Science ®Google Scholar
• GROVES RW, ALLEN MH, ROSS EL, BARKER J, MACDON-ALD DM: Tumour necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression. Br. J. Derma-tol. (1995) i32(3):345–352.
   Google Scholar
• BUTT AM, JONES HC, ABBOTT NJ: Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study. J. Physiol (1990) 429:47–62.
   PubMed Web of Science ®Google Scholar
• MOLLGARD K, SAUNDERS NR: The development of the human blood-brain and blood-CSF barriers. Neuropa-thol. App. Neurobiol. (1986) 12(0337–358.
   PubMed Web of Science ®Google Scholar
• BELL MD, PERRY VH: Adhesion molecule expression on murine cerebral endothelium following the injection of a proinflammagen or during acute neuronal degen-eration. J. Neurocytol. (1995) 24(9):695–710.
   PubMedGoogle Scholar
• TUOMANEN E: Susceptibility to infection and age-related changes in the blood- brain barrier. Neurobiol Age. (1994) i5(6):757–758.
   Google Scholar
• SHARPLES PM, STUART AG, MATTHEWS DSF, AYNSLEY-GREEN A, EYRE JA: Cerebral blood flow and metabo-lism in children with severe head injury. Part 1: Relation to age, Glasgow coma score, outcome, intrac-ranial pressure, and time after injury. J. Neurol. Neuro-surg. Psych. (1995) 58(2):145–152.
   Google Scholar
• JAKOBSEN PH, BATE CAW, TAVERNE J, PLAYFAIR JHL:Malaria - Toxins, Cytokines and Disease. Parasite Im-munol. (1995) 17(5):223–231.
   PubMedGoogle Scholar
• BOLTON SJ, PERRY VH: Differential blood-brain barrierbreakdown and leukocyte recruitment following exci-totoxic lesions in juvenile and adult rats. Exp. Neurol (1998) 154(1):231–240.
   PubMed Web of Science ®Google Scholar
• BAGGIOLINI M: Chemokines and leukocyte traffic. Na-ture (1998) 392(6676):565–568.
   PubMed Web of Science ®Google Scholar
• STRIETER RM, POLVERINI PJ, KUNKEL SL et al.: The func-tional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. (1 99 5) 2 70(45):27348–27357.
   Google Scholar
• YOSHIDA T, IMAI T, KAKIZAKI M, NISHIMURA M, YOSHIE 0: Molecular cloning of a novel C or gamma type che-mokine, SCM-1. FEBS Lett. (1995) 360(2):155–159.
   PubMed Web of Science ®Google Scholar
• MURPHY PM: Chemokine receptors: structure, func-tion and role in microbial pathogenesis. Cyto. Growth Fac. Rev. (1996) 7(0:47–64.
   PubMedGoogle Scholar
• COMBADIERE C, SALZWEDEL K, SMITH ED, TIFFANY HL,BERGER EA, MURPHY PM: Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for 11IV-1. J. Biol. Chem. (1998) 273(37):23799–23804.
   Google Scholar
• YOSHIDA T, IMAI T, KAKIZAKI M, NISHIMURA M, TAKAGIS, YOSHIE 0: Identification of single C motif-1/1ym-photactin receptor XCR1. J. Biol. Chem. (1998) 273 (26):16551–16554.
   PubMedGoogle Scholar
• ZHAO SF, LI W, DORNADULA G et al.: Chemokine recep-tors and the molecular basis for human immunodefi-ciency virus Type 1 entry into peripheral hematopoietic stem cells and their progeny. J. Infect. Dis. (1998) 178(6):1623–1634.
   PubMed Web of Science ®Google Scholar
• ZOU YR, KOTTMANN AH, KURODA M, TANIUCHI I, LITT-MAN DR: Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Na-ture (1998) 393(6685):595–599.
   PubMed Web of Science ®Google Scholar
• •Not all CXC-chemokine-mediated effects are related to de-fense. Study showing that CXC chemokine receptors are in-volved in the architectural development of the brain.
   Google Scholar
• XIA MQ, QIN SX, WU LJ, MACKAY CR, HYMAN BT: Immu-nohistochemical study of the beta-chemokine recep-tors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains. Am. J. PathoL (1998) 153 (1):31–37.
   PubMed Web of Science ®Google Scholar
• SANDERS VJ, PITTMAN CA, WHITE MG, WANG G, WILEYCA, ACHIM CL: Chemokines and receptors in HIV en-cephalitis. Aids (1998) 12 (9):1021–1026.
   PubMed Web of Science ®Google Scholar
• VAN DER VOORN P, TEKSTRA J, BEELEN RH, TENSEN CP,VAN DER VALK P, DE GROOT CJ: Expression of MCP-1 by reactive astrocytes in demyelinating multiple scle-rosis lesions. Am. J. Pathol. (1999) 154(1):45–51.
   PubMed Web of Science ®Google Scholar
• HVAS J, MCLEAN C, JUSTESEN J et al.: Perivascular T cellsexpress the pro-inflammatory chemokine RANTES mRNA in multiple sclerosis lesions. Scand. J. Immunol. (1997) 46(2):195–203.
   PubMed Web of Science ®Google Scholar
• KOSTULAS N, KIVISAKK P, HUANG Y, MATUSEVICIUS D,KOSTULAS V, LINK H: Ischemic stroke is associated with a systemic increase of blood mononuclear cells expressing interleukin-8 mRNA. Stroke (1998) 29(2):462–466.
   PubMed Web of Science ®Google Scholar
• EHRLICH LC, HU S, SHENG WS et al.: Cytokine regulationof human microglial cell IL-8 production. J. Immunol. (1998) 160(4):1944–1948.
   PubMed Web of Science ®Google Scholar
• GHIRNIKAR RS, LEE YL, LI JD, ENG LF: Chemokine inhi-bition in rat stab wound brain injury using antisense oligodeoxynucleotides. Neurosci. Lett. (1998) 247 (1) 21–24.
   PubMed Web of Science ®Google Scholar
• KARPUS WJ, RANSOHOFF RM: Chemokine regulation ofexperimental autoimmune encephalomyelitis: tempo-ral and spatial expression patterns govern disease pathogenesis. J. Immunol (1998) 161(6):2667–2671.
   PubMed Web of Science ®Google Scholar
• •The role of CC chemokines in immune mediated CNS disease.
   Google Scholar
• KENNEDY KJ, STRIETER RM, KUNKEL SL, LUKACS NW, KARPUS WJ: Acute and relapsing experimental autoim-mune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflam-matory protein-lalpha and monocyte chemotactic protein-1. j Neuroimmunol. (1998) 92 (1-2):98–108.
   PubMed Web of Science ®Google Scholar
• GLABINSKI AR, TUOHY VK, RANSOHOFF RM: Expres-sion of chemokines RANTES, MIP-lalpha and GRO-alpha correlates with inflammation in acute experi-mental autoimmune encephalomyelitis. Neuroimmu-nomodulation (1998) 5(3-4) :166–171.
   PubMed Web of Science ®Google Scholar
• MCMANUS C, BERMAN JW, BRETT FM, STAUNTON H, FARRELL M, BROSNAN CF: MCP-1, MCP-2 and MCP-3 ex-pression in multiple sclerosis lesions: an immunohis-tochemical and in situ hybridization study. J. Neuroimmunol. (1998) 86(0:20–29.
   PubMedGoogle Scholar
• BELL MD, TAUB DD, PERRY VH: Overriding the brain's intrinsic resistance to leukocyte recruitment with in-traparenchymal injections of recombinant chemoki-nes. Neuroscience (1996) 74 (1) 283–292.
   PubMed Web of Science ®Google Scholar
• TANI M, FUENTES ME, PETERSON JW et al.: Neutrophil in-filtration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes. j Clin. Invest. (1996) 98(2)529–539.
   Google Scholar
• LIU T, YOUNG PR, MCDONNELL PC, WHITE RF, BARONE FC, FEUERSTEIN GZ: Cytokine-induced neutrophil che-moattractant mRNA expressed in cerebral ischemia. Neurosci. Lett. (1993) 164(1-2):125–128.
   PubMed Web of Science ®Google Scholar
• ANTHONY D, DEMPSTER R, FEARN S et al.: CXC chemoki-nes generate age-related increases in neutrophil-mediated brain inflammation and blood-brain barrier breakdown. Curr. Biol. (1998) 8(16):923–926.
   PubMed Web of Science ®Google Scholar
• ••Despite the plethora of neutrophil chemoattractants, anti-CINC-1 completely abrogates IL-1B-induced neutrophil re-cruitment and neutrophil-mediated damage to the blood-brain barrier.
   Google Scholar
• YAMASAKI Y, MATSUO Y, MATSUURA N, ONODERA H, Y, KOGURE K: Transient increase of cytokine-induced neutrophil chemoattractant, a mem-ber of the interleukin-8 family, in ischemic brain-areas after focal ischemia in rats. Stroke (1995) 26(2) 318–322.
   PubMed Web of Science ®Google Scholar
• ••An anti-CINC antibody reduces cerebral oedema followingtransient middle cerebral artery occlusion.
   Google Scholar
• MATSUMOTO T, IKEDA K, MUKAIDA N et al.: Prevention cerebral edema and infarct in cerebral reperfusion injury by an antibody to interleukin-8. Lab. Invest. (1997) 77(2):119–125.
   PubMed Web of Science ®Google Scholar
• •A neutralising anti-IL-8 antibody significantly reduces brain edema and infarct size in a rabbit model of transient cerebral ischaemia.
   Google Scholar
• SCOTT BL, JANKOVIC J: Delayed-onset progressive disorders after static brain lesions. Neurol-ogy (1996) 46(0:68-74. C Anthonyt, Katherine Walker & V Hugh Perry for correspondence for Neuroscience at Southampton, University of, Biomedical Sciences Building, S016 7PX, UK.: +44 1703 595998; Fax: + 44 1703 592711;: [email protected]
   Google Scholar